- Article metrics
- Last updated: Sat, 18 May 2024 4:30:45 Z
Validation of the Meet-URO score in metastatic clear cell renal cell carcinoma patients receiving second or third-line tyrosine kinase inhibitors-immune checkpoint inhibitors combination therapy
Access & Citations
-
- 417
- Article Accesses
-
- 0
- Web of Science
-
- 1
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.